Cite
HARVARD Citation
Mirhaidari, G. et al. (2020). Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis. Advanced healthcare materials. 9 (24), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mirhaidari, G. et al. (2020). Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis. Advanced healthcare materials. 9 (24), p. n/a. [Online].